SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kushi Kullar who wrote (1583)6/30/1998 3:50:00 PM
From: DZOO  Read Replies (1) of 1762
 
Still here but not much to write home about. Here is the latest news:

IDEC Pharmaceuticals Corp. (IDPH) 23 3/4 -1 3/4: Vector Securities initiates coverage of biotechnology concern with "neutral" rating; there is near-term risk, although longer term, the stock could be rewarding; believes 1999 consensus estimates are high and revisions could hamper near-term stock performance.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News